Lara Green, PA
Surgical · Norman, OKNPI 1558339184
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 14 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 9 manufacturers, the largest accounting for just 22.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $178, 3.5 times the $51 reported in 2021. That places this record below the midpoint for surgical clinicians in OK, where the typical reported total is $539.
Across 14 payments — averaging $19.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$63
- Astellas Pharma US Inc$39
- Immunitybio, Inc.$35
- Bayer$34
- Teleflex LLC$32
- Merck$24
- plus $50 from 3 others
What the payments were for
- Food & beverage$276100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 4 | $63 |
| Astellas Pharma US Inc | 2 | $39 |
| Immunitybio, Inc. | 1 | $35 |
| Bayer | 2 | $34 |
| Teleflex LLC | 1 | $32 |
| Merck | 1 | $24 |
| Intuitive Surgical | 1 | $20 |
| Redhill Biopharma Inc. | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
How this compares
$276 in reported general payments places this provider in the 35th percentile of 94 surgical providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 26 | $1,802 |
| Omeprazole | 47 | $504 |
| Ondansetron OdtOndansetron | 22 | $159 |
Paid to pharmacies, not to this prescriber.
Other surgical in Norman
- Amanda LewisNorman$2K
- John GiraldoNorman$946
- Leigh LangleyNorman$539
- Kayla HaleOklahoma City$36K
- Randall PapeOklahoma City$25K
- Anne EdmondsTulsa$15K
- Ian GordonOklahoma City$14K
- Isaac EdmondsTulsa$7K
- Camryn CorwinTulsa$5K
- Eduardo GarciaOklahoma City$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.